CVSI Stock - CV Sciences, Inc.
Unlock GoAI Insights for CVSI
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $15.71M | $16.00M | $16.20M | $20.05M | $24.43M |
| Gross Profit | $7.17M | $7.08M | $5.55M | $8.62M | $11.01M |
| Gross Margin | 45.6% | 44.3% | 34.2% | 43.0% | 45.1% |
| Operating Income | $-2,190,000 | $3.36M | $-6,847,000 | $-18,446,000 | $-22,592,000 |
| Net Income | $-2,394,000 | $3.10M | $-8,214,000 | $-15,554,000 | $-22,284,000 |
| Net Margin | -15.2% | 19.4% | -50.7% | -77.6% | -91.2% |
| EPS | $-0.01 | $0.02 | $-0.06 | $-0.14 | $-0.22 |
CV Sciences, Inc. operates as a life science company in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The Consumer Products segment develops, manufactures, and markets plant-based dietary supplements and hemp-based cannabidiol (CBD) products under the PlusCBD, ProCBD, HappyLane, CV Acute, CV Defense, and PlusCBD Pet brand names in various health care sectors, including nutraceutical, beauty care, specialty foods, and pet products. It sells its products through its websites, internet sales, elect distributors, brick and mortar retailers, and select e-tailers. The Specialty Pharmaceutical segment focuses on developing and commercializing cannabinoids to treat medical indications. This segment is developing drug candidate CVSI-007 that combines CBD and nicotine in treatment of smokeless tobacco use and addiction. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.
Visit WebsiteEarnings History & Surprises
CVSIEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 12, 2026 | — | — | — | — |
Q4 2025 | Nov 13, 2025 | — | $-0.00 | — | — |
Q3 2025 | Aug 13, 2025 | — | $-0.00 | — | — |
Q2 2025 | May 14, 2025 | — | $-0.00 | — | — |
Q1 2025 | Mar 27, 2025 | — | $-0.00 | — | — |
Q4 2024 | Nov 14, 2024 | — | $-0.00 | — | — |
Q3 2024 | Aug 13, 2024 | — | $-0.00 | — | — |
Q2 2024 | May 14, 2024 | — | $-0.00 | — | — |
Q1 2024 | Mar 28, 2024 | $-0.01 | $-0.01 | 0.0% | = MET |
Q4 2023 | Nov 14, 2023 | $-0.01 | $-0.00 | +71.1% | ✓ BEAT |
Q3 2023 | Aug 14, 2023 | $-0.01 | $-0.01 | 0.0% | = MET |
Q2 2023 | May 15, 2023 | $-0.01 | $0.04 | +500.0% | ✓ BEAT |
Q1 2023 | Mar 29, 2023 | $-0.02 | $-0.02 | 0.0% | = MET |
Q4 2022 | Nov 14, 2022 | $-0.02 | $-0.01 | +50.0% | ✓ BEAT |
Q3 2022 | Aug 15, 2022 | $-0.03 | $-0.03 | 0.0% | = MET |
Q2 2022 | May 16, 2022 | $-0.01 | $-0.02 | -33.3% | ✗ MISS |
Q1 2022 | Mar 31, 2022 | $-0.03 | $-0.08 | -220.0% | ✗ MISS |
Q4 2021 | Nov 15, 2021 | $-0.00 | $-0.00 | -105.6% | ✗ MISS |
Q3 2021 | Aug 12, 2021 | $-0.02 | $-0.03 | -28.6% | ✗ MISS |
Q2 2021 | May 13, 2021 | $-0.02 | $-0.03 | -33.3% | ✗ MISS |
Frequently Asked Questions about CVSI
What is CVSI's current stock price?
What is the analyst price target for CVSI?
What sector is CV Sciences, Inc. in?
What is CVSI's market cap?
Does CVSI pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to CVSI for comparison